Drug Profile
CSL 412
Alternative Names: CSL412; CSL412 ISCOMATRIX® FluLatest Information Update: 21 Jul 2015
Price :
$50
*
At a glance
- Originator CSL
- Class Influenza virus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Influenza virus infections
Most Recent Events
- 31 May 2007 Phase-II clinical trials in Influenza virus infections (prevention) in United Kingdom (Parenteral)